Cancer , HealthyNCT07450703
The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination
A study testing HEALTH BELİEF MODEL in people with Cancer , Healthy and HPV - Anogenital Human Papilloma Virus Infection, run by University of Gaziantep.
Trial summary
This study aims to examine the effects of education provided to mothers of children aged 9-15 within the framework of the Health Belief Model on mothers' knowledge, attitudes, and behaviors about Human Papillomavirus (HPV), and their willingness to have their children vaccinated against HPV. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cancer , Healthy, HPV - Anogenital Human Papilloma Virus Infection, Health Belief Model
- What is being tested?
- HEALTH BELİEF MODEL
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Apr 2026to 1 Dec 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Literate and able to understand and speak Turkish
- Mother of a child aged 9-15 years
- Did not receive any HPV-related education in the past 6 months
- Has not had HPV vaccination previously
- Willing to participate voluntarily
Who cannot join
- Presence of serious physical or cognitive impairment preventing participation
- Refusal to provide informed consent
- Already vaccinated against HPV
- Already received HPV-related education within the last 6 months
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Effect of Health Belief Model-Based Education on Mothers of Children Aged 9-15 Years: Impact on HPV Knowledge Level and Child Vaccination
This study aims to examine the effects of education provided to mothers of children aged 9-15 within the framework of the Health Belief Model on mothers' knowledge, attitudes, and behaviors about Human Papillomavirus (HPV), and their willingness to have their children vaccinated against HPV. The study, designed with a randomized controlled experimental design, will be conducted at three different Family Health Centers in Gaziantep and will consist of both experimental and control groups. Mothers in the experimental group will receive a three-session visually supported education program prepared by Yıldız USCA, while the control group will receive routine information using HPV brochures from the Ministry of Health. Data collection tools include a personal information form, an HPV knowledge scale, and an HPV Health Belief Model scale.
- Being tested
- HEALTH BELİEF MODEL
- Keywords
- HUMAN PAPİLLOMA VIRUS, WOMEN HEALTH, VACCINE EDUCATİON
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HEALTH BELİEF MODELBehavioural
In social psychology, the health belief model (HBM) is a psychological framework used to explain and predict individuals' potentially detrimental behaviors, attitudes and beliefs on their health. Developed in the 1950s by social psychologists at the United States Public Health Service, the model examines how perceptions of susceptibility to illness, the severity of health conditions, the benefits of preventive care, and barriers to healthcare influence behavior. The HBM is widely used in health behavior research and public health interventions to understand and promote engagement in health-protective behaviors
| Study group | Role | What they receive |
|---|---|---|
| FAMILY HEALTH CENTER NO. 19 | Experimental | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
| FAMILY HEALTH CENTER NO. 31 | Experimental | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
| BURAK FAMILY HEALTH CENTER | Experimental | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
| BURAK FAMILY HEALTH CENTER- control grup | Placebo comparator | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
| FAMILY HEALTH CENTER NO. 19- control grup | Placebo comparator | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
| FAMILY HEALTH CENTER NO. 31- control grup | Placebo comparator | Not described Receives: Behavioral: HEALTH BELİEF MODEL |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in HPV Knowledge Score
Health Belief Model Scale(HPVA-SIM): The scale consists of 14 items and four sub-dimensions: perceived benefit (Items 1-3), perceived sensitivity (Items 4-5), perceived seriousness (Items 6-9), and perceived barrier (Items 10-14). The Cronbach Alpha reliability coefficient was calculated as .78 for perceived benefit, .72 for perceived sensitivity, .78 for perceived severity, and .71 for perceived barrier in the sub-dimensions of the scale http://dx.doi.org/10.1016 HPV Knowledge Scale (HPV-KÖ): The HPV-KÖ includes three sub-dimensions of 29 items.Factor 1: General HPV knowledge, Factor 2: Knowledge of HPV screening tests, Factor 3: General HPV vaccine knowledge, Factor 4: Knowledge of the current HPV vaccination program. The Cronbach α value for the 29 items of the original scale was reported as 0.83, and the consistency of the scale was reported to be high for this value doi.org/10.4274/jtgga.galenos.2023.2022-10-9
Measured: 1 month after the education program
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2026
- Study start1 Apr 2026 (estimated)
- Primary completion1 Nov 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer , HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Gaziantep
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yildiz Usca, University of Gaziantep
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07450703
- Sponsor's protocol ID
- Other Identifier
- Status last verified
- Mar 2026
- First submitted
- 25 Sep 2025
- Last updated
- 5 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No